Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott McComb

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophagesScott McComb, Erin Cessford, Norah A Alturki, et al.
Cancers|June 24, 2022
A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell CytotoxicitySerena Cortés-Kaplan, Reem Kurdieh, Mohamed S Hasim, et al.
Cancer Letters|December 26, 2025
Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary diseaseShelby Kaczmarek, Donghyeon Jo, Safa Ghaziasgar, et al.
Frontiers in Immunology|March 24, 2025
Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expressionDong-Hyeon Jo, Shelby Kaczmarek, Abrar Ul Haq Khan, et al.
Cytotherapy|December 18, 2024
Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studiesDonald J Bastin, Marisa K Kilgour, Risa Shorr, et al.
Science Translational Medicine|May 20, 2016
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALLScott McComb, Júlia Aguadé-Gorgorió, Lena Harder, et al.
Systematic Reviews|January 18, 2023
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocolManoj M Lalu, Natasha Kekre, Joshua Montroy, et al.
The Journal of Biological Chemistry|June 15, 2018
Differentiated macrophages acquire a pro-inflammatory and cell death-resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1Dikchha Rijal, Ardeshir Ariana, Andrew Wight, et al.
Frontiers in Immunology|August 8, 2022
Programmable Attenuation of Antigenic Sensitivity for a Nanobody-Based EGFR Chimeric Antigen Receptor Through Hinge Domain TruncationScott McComb, Tina Nguyen, Alex Shepherd, et al.
Oncotarget|May 26, 2018
MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cellsDimitra Tripolitsioti, Karthiga Santhana Kumar, Anuja Neve, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophagesScott McComb, Erin Cessford, Norah A Alturki, et al.
Cancers|June 24, 2022
A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell CytotoxicitySerena Cortés-Kaplan, Reem Kurdieh, Mohamed S Hasim, et al.
Cancer Letters|December 26, 2025
Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary diseaseShelby Kaczmarek, Donghyeon Jo, Safa Ghaziasgar, et al.
Frontiers in Immunology|March 24, 2025
Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expressionDong-Hyeon Jo, Shelby Kaczmarek, Abrar Ul Haq Khan, et al.
Cytotherapy|December 18, 2024
Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studiesDonald J Bastin, Marisa K Kilgour, Risa Shorr, et al.
Science Translational Medicine|May 20, 2016
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALLScott McComb, Júlia Aguadé-Gorgorió, Lena Harder, et al.
Systematic Reviews|January 18, 2023
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocolManoj M Lalu, Natasha Kekre, Joshua Montroy, et al.
The Journal of Biological Chemistry|June 15, 2018
Differentiated macrophages acquire a pro-inflammatory and cell death-resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1Dikchha Rijal, Ardeshir Ariana, Andrew Wight, et al.
Frontiers in Immunology|August 8, 2022
Programmable Attenuation of Antigenic Sensitivity for a Nanobody-Based EGFR Chimeric Antigen Receptor Through Hinge Domain TruncationScott McComb, Tina Nguyen, Alex Shepherd, et al.
Oncotarget|May 26, 2018
MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cellsDimitra Tripolitsioti, Karthiga Santhana Kumar, Anuja Neve, et al.
Pageof 4